Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Treatment of Down Syndrome Children With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Under the Age of 4 Years

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00369317
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:19.958907+00:00
Published At
2015-01-13T00:00:00+00:00
Record Updated At
2022-01-28
Results Posted At
2015-01-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Childhood Acute Basophilic Leukemia", "Childhood Acute Eosinophilic Leukemia", "Childhood Acute Erythroleukemia (M6)", "Childhood Acute Megakaryocytic Leukemia (M7)", "Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)", "Childhood Acute Monoblastic Leukemia (M5a)", "Childhood Acute Monocytic Leukemia (M5b)", "Childhood Acute Myeloblastic Leukemia With Maturation (M2)", "Childhood Acute Myeloblastic Leukemia Without Maturation (M1)", "Childhood Acute Myelomonocytic Leukemia (M4)", "Childhood Myelodysplastic Syndromes", "de Novo Myelodysplastic Syndromes", "Secondary Acute Myeloid Leukemia", "Secondary Myelodysplastic Syndromes", "Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-01-28"
protocolSection.identificationModule.nctId
"NCT00369317"
protocolSection.identificationModule.officialTitle
"The Treatment of Down Syndrome Children With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Under the Age of 4 Years"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-01-13"

Study condition terms

  • Childhood Acute Basophilic Leukemia (protocolSection.conditionsModule.conditions)
  • Childhood Acute Eosinophilic Leukemia (protocolSection.conditionsModule.conditions)
  • Childhood Acute Erythroleukemia (M6) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Megakaryocytic Leukemia (M7) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Monoblastic Leukemia (M5a) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Monocytic Leukemia (M5b) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloblastic Leukemia With Maturation (M2) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myeloblastic Leukemia Without Maturation (M1) (protocolSection.conditionsModule.conditions)
  • Childhood Acute Myelomonocytic Leukemia (M4) (protocolSection.conditionsModule.conditions)
  • Childhood Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • de Novo Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Secondary Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Secondary Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.